Profile Picture
Rewards
  • Search
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
    • Real Estate
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

UNLV shooting suspect
Stewart to replace wife Pruett
Accuses Allen of being rude
Jackson, Nyong'o dating?
Suing Hauser over coffee
Listeria contamination recall?
British poet, activist dies
Fake aircraft parts scandal
UNLV-Dayton game canceled
Reality show winner revealed
‘I loved him dearly’
Saints claim Monty Rice
Oilers beat Hurricanes
In merger talks w/ Santos
China's exports grow
AI powered image generator
Reaches 3,000 career points
3-yr extension w/ Dolphins
Zach LaVine injury update
Dončić makes NBA history
Seasons 3, 4 in the works
Tops quarterly results
‘The Brothers Sun’ trailer
FR to ramp up hotel checks
Reds sign Jeimer Candelario
Pearl Harbor Day
Washington Post strike
Season-high 50 points
US weekly jobless claims rise
Tomlin dismissed from team
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
1,740 results
The Argus2mon
Japan approves its first Alzheimer’s drug
Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s disease that was jointly developed by Japanese and US pharmaceutical companies. It is the first drug for treatment of the ...
The Times of Israel on MSN
8h
Ichilov first hospital outside US to treat Alzheimer’s patients with new drug Lecanemab
The post Ichilov first hospital outside US to treat Alzheimer’s patients with new drug Lecanemab appeared first on The Times ...
Benzinga.com on MSN1d
Japan Approves Marijuana-Derived Medicines, Adopt 7-Year Prison Sentences For Recreational Use
Japan’s Parliament passed a bill Wednesday legalizing medical products derived from cannabis. The news comes some three weeks ...
High Times16h
Japan Amends Cannabis Law Allowing for Medicinal Products, Criminalizing Rec Use
Like many other Asian countries, cannabis in Japan is illegal for both medicinal and recreational use. Though even with some of the world’s strictest cannabis-related laws, the future for cannabis in ...
The Drive18d
Japan Approved To Buy 400 Tomahawk Cruise Missiles
The approval comes after years of talk that Japan would procure long-range land attack cruise missile capability via Tomahawk and is another glaring example of the country's changing military ...
Nikkei Asia26d
Japan cabinet approves 13.2tn yen extra budget to fight inflation
TOKYO (Kyodo) -- Japan's cabinet approved Friday an extra budget of 13.20 trillion yen ($87 billion) for the financial year that ends next March to fund a new economic package designed to mitigate ...
GovCon Wire17d
State Department Approves $2.4B Sale of Tomahawk Missiles to Japan
The State Department approved a possible sale of Tomahawk weapon systems to the government of Japan, paving the way for the Defense Security Cooperation Agency to notify the U.S. Congress of the ...
17h
Japan prosecutors to investigate ruling party heavyweights over fundraising -Yomiuri
Japanese prosecutors will start investigating several dozen ruling party lawmakers, including current ministers, next week over unreported fundraising of over 100 million yen ($680,000), the Yomiuri ...
Hosted on MSN18d
Japan Approved To Buy 400 Tomahawk Cruise Missiles
The State Department on Friday approved a potential $2.35 billion sale of 400 Tomahawk cruise missiles to Japan. The deal would allow for Japan to receive up to 200 Tomahawk Block IV and 200 ...
Yahoo News18d
Japan Approved To Buy 400 Tomahawk Cruise Missiles
The State Department on Friday approved a potential $2.35 billion sale of 400 Tomahawk cruise missiles to Japan. The deal would allow for Japan to receive up to 200 Tomahawk Block IV and 200 Tomahawk ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Get the Bing App
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices